NCT02196532

Brief Summary

Optical coherence tomography (OCT) is a non-invasive retinal imaging technology that can provide high-resolution cross-sectional images of the peripapillary retinal nerve fiber layer (RNFL) and measure its thickness. A reduction of the RNFL thickness has been detected in several neurodegenerative diseases, such as multiple sclerosis, CADASIL and Alzheimer's disease. Different studies have reported RNFL changes also in migraine, is a common hereditary chronic neurovascular disorder, characterized by dysfunction of the autonomic nervous system. The pathophysiology of migraine has not been fully clarified, but there is increasing evidence that episodes of migraine with aura are initiated by a focal reduction in cerebral blood flow, which occurs most commonly in the posterior region of one hemisphere. Although vasoconstriction of cerebral and retinal blood vessels is a transient phenomenon, the chronic nature of the migraine might cause permanent structural abnormalities of the brain and also of the retina, which may correlate with RNFL thinning. Previous studies on this subject, however, reported contradicting results. Some investigations reported reductions of the RNFL thickness while others did not. In the present study, in order to determine whether RNFL thickness is reduced in migraine patients, the investigators performed a meta-analysis and systematically evaluated RNFL thickness measurements with OCT in a series of migraine patients and in the healthy control groups.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2014

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2014

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

July 17, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 22, 2014

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
Last Updated

July 22, 2014

Status Verified

July 1, 2014

Enrollment Period

1 year

First QC Date

July 17, 2014

Last Update Submit

July 21, 2014

Conditions

Keywords

retinal nerve fiber layer thicknessoptical coherence tomographymigraine

Outcome Measures

Primary Outcomes (1)

  • Retinal Nerve Fiber Layer Thickness

    Retinal nerve fiber layer thickness included average thickness (360° measurement), temporal quadrant thickness (316-45°), superior quadrant thickness (46-135°), nasal quadrant thickness (136-225°) and inferior quadrant thickness (226-315°)was measured by OCT.

    Baseline

Study Arms (2)

migraine group

Patients with migraine

Device: Device: Optical coherence tomography

healthy control

Sex- and agematched healthy subjects

Device: Device: Optical coherence tomography

Interventions

healthy controlmigraine group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Migraine patients and healthy subjects were included and underwent OCT examinations

You may qualify if:

  • case-control studies;
  • patients with Migraine were compared with healthy controls;
  • all subjects underwent RNFL thickness measurement by OCT;
  • studies should provide the data of peripapillary RNFL thickness;
  • sample size ≥10 in each group.

You may not qualify if:

  • authors did not make RNFL measurements;
  • study without healthy control group;
  • the outcome values can not be used for meta-analysis;
  • duplicated articles.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongshan hospital, Fudan University

Shanghai, Shanghai Municipality, 200032, China

RECRUITING

MeSH Terms

Conditions

Migraine Disorders

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Yifan Feng, PhD

    Fudan University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yifan Feng, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Zhongshan hospital, Fudan University

Study Record Dates

First Submitted

July 17, 2014

First Posted

July 22, 2014

Study Start

July 1, 2014

Primary Completion

July 1, 2015

Study Completion

July 1, 2015

Last Updated

July 22, 2014

Record last verified: 2014-07

Locations